跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 26 条关于
“Akesa”
全部
26
临床试验
0
药物
4
机构
5
资讯
17
9个月前
APAC Region Emerges as Global Clinical Trial Powerhouse with 50,000 Expected Studies
去年
Akeso Biopharma Secures $250 Million to Advance Global Clinical Trials
去年
Akeso Completes Patient Enrollment in Phase III Trial Comparing Ivonescimab for First-Line Squamous NSCLC Treatment
2年前
Akeso Highlights Bispecific Antibody Data at ESMO 2024, Demonstrating Promising Results in Multiple Cancers
去年
Akeso Initiates Phase 3 Trial of Ivonescimab Plus Ligufalimab in Head and Neck Cancer
6个月前
INOVIO and Akeso Partner to Test Novel DNA-Bispecific Antibody Combination for Glioblastoma Treatment
2年前
Akeso Initiates Phase III Trial of Cadonilimab Bispecific Antibody for PD-L1 Negative NSCLC
2年前
Akeso's Ivonescimab Demonstrates Superiority Over Pembrolizumab in Lung Cancer Trial
去年
Akeso's Ivonescimab Enrolls First Patient in Phase III Biliary Tract Cancer Trial
去年
Akeso's Ivonescimab Enrolls First Patient in Phase 3 Biliary Tract Cancer Trial
第 1 页,共 2 页
上一页
下一页